155 related articles for article (PubMed ID: 11066591)
1. Fragmented bodies, legal privilege, and commodification in science and medicine.
Perry MM
Spec Law Dig Health Care Law; 2000 Jul; (256):9-49. PubMed ID: 11066591
[No Abstract] [Full Text] [Related]
2. Fragmented bodies, ideal privilege, and commodification in science and medicine.
Perry MM
Maine Law Rev; 1999; 51(1):169-210. PubMed ID: 12741402
[No Abstract] [Full Text] [Related]
3. Do we own our bodies?
Calabresi G
Health Matrix Clevel; 1991; 1(1):5-18. PubMed ID: 10121879
[No Abstract] [Full Text] [Related]
4. Protecting innovation in biotechnology startups.
Steffe EK; Shea TJ
Nat Biotechnol; 2003 Jul; 21 Suppl():BE51-3. PubMed ID: 12874982
[No Abstract] [Full Text] [Related]
5. Are we morally obligated to make gifts of our bodies?
Murray TH
Health Matrix Clevel; 1991; 1(1):19-29. PubMed ID: 10121877
[No Abstract] [Full Text] [Related]
6. A counselor's dose of preventive medicine.
Redlick D; Kapner V
Nat Biotechnol; 2002 Jul; 20 Suppl():BE51-3. PubMed ID: 12089589
[No Abstract] [Full Text] [Related]
7. The market for human tissue.
Mahoney JD
Va Law Rev; 2000 Mar; 86(2):163-223. PubMed ID: 12718304
[No Abstract] [Full Text] [Related]
8. Our bodies, our families. The family's role in organ donation.
Dougherty CJ
Second Opin; 1993 Oct; 19(2):59-67. PubMed ID: 10129972
[TBL] [Abstract][Full Text] [Related]
9. Napster case spills into biotech sector.
Bouchie A
Nat Biotechnol; 2004 Sep; 22(9):1185-6. PubMed ID: 15384189
[No Abstract] [Full Text] [Related]
10. The new French resistance: commodification rejected?
Dickenson D
Med Law Int; 2005; 7(1):41-63. PubMed ID: 16622985
[No Abstract] [Full Text] [Related]
11. Regulating life and death: the modification and commodification of nature.
Trew A
Univ Toledo Law Rev; 1998; 29(2):271-326. PubMed ID: 16514754
[No Abstract] [Full Text] [Related]
12. Policy entrepreneurship in the Social Transformation of American Medicine: the rise of managed care and managed competition.
Oliver TR
J Health Polit Policy Law; 2004; 29(4-5):701-33; discussion 1005-19. PubMed ID: 15602842
[No Abstract] [Full Text] [Related]
13. Altruism's limits: law, capacity, and organ commodification.
Goodwin M
Rutgers Law Rev; 2004; 56(2):305-407. PubMed ID: 16755702
[No Abstract] [Full Text] [Related]
14. Neither Moore nor the market: alternative models for compensating contributors of human tissue.
Harrison CH
Am J Law Med; 2002; 28(1):77-105. PubMed ID: 12025539
[No Abstract] [Full Text] [Related]
15. Toward a just model of alienability of human tissue.
Budds B
Univ San Francisco Law Rev; 2003; 37(3):757-82. PubMed ID: 16514784
[No Abstract] [Full Text] [Related]
16. Markets for organs: myths and misconceptions.
Kaserman D
J Contemp Health Law Policy; 2002; 18(2):567-81. PubMed ID: 12236143
[No Abstract] [Full Text] [Related]
17. Owning our bodies: an examination of property law and biotechnology.
Gold R
San Diego Law Rev; 1995; 32(4):1167-247. PubMed ID: 11656846
[No Abstract] [Full Text] [Related]
18. Starr on the corporatization and commodification of health care: the sequel.
Havighurst CC
J Health Polit Policy Law; 2004; 29(4-5):947-67; discussion 1005-19. PubMed ID: 15602854
[No Abstract] [Full Text] [Related]
19. The human body as property? Possession, control and commodification.
Goold I; Skene L; Herring J; Greasley K
J Med Ethics; 2014 Jan; 40(1):1-2. PubMed ID: 24336397
[No Abstract] [Full Text] [Related]
20. Patient vs. disease in medicine: Historical perspectives and contemporary concerns.
von Engelhardt D
J Nephrol; 2004; 17(4):611-8. PubMed ID: 15372428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
